FDA Inspection 1022399 — LifeShare Blood Center

LifeShare Blood Center — FEI 3001632629

The FDA completed an inspection of LifeShare Blood Center on July 26, 2017 in Bossier City, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 26, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Bossier City, LA (United States)